Search results (253)
« Back to PublicationsTargeting the UFL1-AKT cascade suppresses triple-negative breast cancer progression.
Journal article
Yang X. et al, (2026), Nature communications, 17
S-acyl transferase ZDHHC13 modulates tumor microenvironment interactions to suppress metastasis in melanoma models.
Journal article
Li H. et al, (2025), The Journal of clinical investigation, 135
MITF, TFEB, and TFE3 drive distinct adaptive gene expression programs and immune infiltration in melanoma.
Journal article
Dias D. et al, (2025), Cell reports, 44
Corrigendum to 'TBX3 Promotes Melanoma Migration by Transcriptional Activation of ID1, which Prevents Activation of E-Cadherin by MITF' Journal of Investigative Dermatology, Volume 141, Issue 9, September 2021, Pages 2250-2260.
Journal article
Peres J. et al, (2025), The Journal of investigative dermatology, 145, 2647 - 2648
SETD6 mediates selective interaction and genomic occupancy of BRD4 and MITF in melanoma cells.
Journal article
Biton TE. et al, (2025), NAR cancer, 7
UFMylation maintains tumor suppressor pVHL stability by activating the deubiquitinase BAP1.
Journal article
Yang X. et al, (2025), Science advances, 11
Single-Cell Transcriptomic Landscape Deciphers Intratumoral Heterogeneity and Subtypes of Acral and Mucosal Melanomas.
Journal article
Li Y. et al, (2025), Clinical cancer research : an official journal of the American Association for Cancer Research, 31, 2495 - 2514
Metabolic buffering suppresses phenotype switching in cancer
Preprint
Ramírez-Sánchez A. et al, (2025)
Fatty acid uptake activates an AXL-CAV1-β-catenin axis to drive melanoma progression.
Journal article
Chocarro-Calvo A. et al, (2025), Genes & development, 39, 463 - 489
The Lipid Droplet Protein DHRS3 Is a Regulator of Melanoma Cell State
Journal article
Johns E. et al, (2025), Pigment Cell & Melanoma Research, 38
SETD6 Mediates Selective Interaction and Genomic Occupancy of BRD4 and MITF in Melanoma cells
Preprint
Biton TE. et al, (2025)
Functional specialization of MITF, TFEB and TFE3 drives radically distinct adaptive gene expression programs in melanoma.
Journal article
Dias D. et al, (2024), bioRxiv
TPC1 regulates melanoma tumourigenesis via mTORC1 and TFEB.
Journal article
Jin X. et al, (2024), Heliyon, 10
A High-Throughput Drug Repurposing Strategy to Treat TBX2 and/or TBX3 Dependent Cancers.
Journal article
Bleloch JS. et al, (2024), Cancer medicine, 13
The lipid droplet protein DHRS3 is a regulator of melanoma cell state
Preprint
Johns E. et al, (2024)